Diagnostic Performance of Anti–Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma

医学 无症状的 队列 生物标志物 病毒 病毒学 人口 队列研究 内科学 疾病 免疫学 病毒性疾病 门诊部 入射(几何) 肿瘤科 病理
作者
S H Li,Feng Li,Shiji Wu,Minzhong Tang,Xiao Zhen-zhou,Tingdong Li,Ningshao Xia,Hai‐Qiang Mai,Ming-Fang Ji,Lin‐Quan Tang,P85-Ab Collaborative Group,Li Yuan,Li Yuan,Hui-Jun Li,Ying-Ying Lin,Wan-Li Liu,Biao-Hua Wu,Shan Xing,Yansong Chen,Yaxian Wu
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:12 (5): 478-487 被引量:2
标识
DOI:10.1001/jamaoncol.2026.0251
摘要

Importance: It remains uncertain which Epstein-Barr virus (EBV)-related biomarkers provide the most reliable diagnostic performance for suspected nasopharyngeal carcinoma (NPC) in outpatient settings, especially regarding the novel anti-EBV BNLF2b total antibody (P85-Ab) assay. Clarifying their accuracy is critical to improving early detection and reducing misdiagnosis. Objective: To evaluate the diagnostic performance of the P85-Ab assay in suspected NPC in outpatient settings and compare it head-to-head with EBV viral capsid antigen (VCA)-immunoglobulin A (IgA), EBV early antigen (EA)-IgA, and EBV nuclear antigen 1 (EBNA1)-IgA. Design, Setting, and Participants: A prospective, multicenter cohort study was conducted between April 2021 and March 2024, with a median follow-up of 27.2 months in outpatient clinics across 5 medical centers in China. Key inclusion criteria comprised clinically suspected NPC. Data were analyzed from June 2025 to July 2025. Exposures: P85-Ab was tested using chemiluminescent immunoassay. VCA-IgA, EA-IgA, and EBNA1-IgA were tested via enzyme-linked immunosorbent assays. Main Outcomes and Measure: Primary outcomes included sensitivity and specificity of P85-Ab. Results: A total of 3795 eligible participants were consecutively recruited. After excluding individuals with low-quality samples or lost to follow-up, 3777 participants were included in the final analysis (1680 with NPC and 2097 without NPC). Among the 3777 evaluated participants (median [IQR] age, 49.0 [37.0-58.0] years; 65 % male), P85-Ab demonstrated superior diagnostic performance, with a sensitivity of 93.0% (95% CI, 91.6-94.0) and specificity of 97.3% (95% CI, 96.5-97.9). Other biomarkers showed lower sensitivity (ranging from 60.4% to 93.0%) and specificity (<90%). P85-Ab maintained high sensitivity among asymptomatic individuals (92.0%; 95% CI, 85.9-95.6) and those presenting with NPC-nonspecific symptoms (88.4%; 95% CI, 75.5-94.9), with no additional diagnostic benefit observed from the triplet-antibody strategy combining P85-Ab, VCA-IgA, and EBNA1-IgA. However, among participants with NPC-specific symptoms, the triplet-antibody strategy improved sensitivity compared with P85-Ab alone (95.9%; 95% CI, 94.8-96.8 vs 93.1%; 95% CI, 91.7-94.3; P < .001). Conclusions and Relevance: In this cohort study, P85-Ab was a robust and accurate biomarker for suspected NPC in outpatient settings. P85-Ab alone may be suggested for populations with asymptomatic or NPC-nonspecific symptoms, and combining P85-Ab with VCA-IgA and EBNA1-IgA may be suggested for populations with NPC-specific symptoms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Harry完成签到,获得积分10
刚刚
刚刚
1秒前
Lina发布了新的文献求助10
1秒前
沐泽完成签到 ,获得积分10
1秒前
慕青的应助被凡人烦事采纳,获得10
2秒前
隐形的哈密瓜完成签到,获得积分10
2秒前
hhhee完成签到,获得积分10
2秒前
执着的新烟完成签到 ,获得积分10
2秒前
小泥熊发布了新的文献求助30
2秒前
2秒前
2秒前
2秒前
2秒前
打打的应助被江江采纳,获得20
3秒前
今后的应助被友好的人英采纳,获得10
3秒前
u0u0uu0关注了科研通微信公众号
3秒前
英姑的应助被欢喜的芷文采纳,获得10
3秒前
4秒前
smiling发布了新的文献求助10
4秒前
4秒前
jennie完成签到 ,获得积分10
4秒前
ivy1991完成签到,获得积分10
4秒前
热心的粉红小企鹅完成签到,获得积分10
4秒前
4秒前
5秒前
领导范儿的应助被阿白采纳,获得10
5秒前
5秒前
6秒前
6秒前
风笛发布了新的文献求助10
7秒前
7秒前
spoon1026发布了新的文献求助10
7秒前
杨庄鸡块发布了新的文献求助10
7秒前
jc哥发布了新的文献求助10
7秒前
wang完成签到,获得积分10
7秒前
踏实沂发布了新的文献求助10
8秒前
热情的访枫完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181279
求助须知:如何正确求助?哪些是违规求助? 9571198
关于积分的说明 21817073
捐赠科研通 7777612
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479519